Literature DB >> 3558489

Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle.

K Kosugi, D W Morel, P E DiCorleto, G M Chisolm.   

Abstract

Oxidized LDL (o-LDL) is toxic to a variety of cultured cells. Preliminary results suggested that susceptibility is enhanced by cell proliferation. As a step toward determining the mechanism of cytotoxicity, we chose to identify the cell cycle phase(s) during which exposure of cultured human fibroblasts to o-LDL leads to death. Cytochalasin B, which blocks cell migration and proliferation, and irradiation, which prevents mitosis but not migration, both blocked cytotoxicity. Colchicine, which arrests cells in mitosis but does not inhibit DNA synthesis, did not block cytotoxicity. Treatment of cells with hydroxyurea, which blocks cells prior to S phase, prevented cell death. Addition of o-LDL to cells immediately after S phase allowed mitosis without death. The above results coupled with results using cells synchronized by three different means indicate that cell death is selective for proliferating cells and occurs after exposure to o-LDL during S phase. Understanding the mechanism of o-LDL-induced death may have implications for tissue damage in vivo in the numerous instances of pathology in which oxidized lipoproteins or lipids are present.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558489     DOI: 10.1002/jcp.1041300302

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

Authors:  J A Berliner; M C Territo; A Sevanian; S Ramin; J A Kim; B Bamshad; M Esterson; A M Fogelman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 3.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

4.  Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.

Authors:  E Ehrenwald; P L Fox
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

5.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 6.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

7.  Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60.

Authors:  M K Cathcart; G M Chisolm; A K McNally; D W Morel
Journal:  In Vitro Cell Dev Biol       Date:  1988-10

8.  Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.

Authors:  F Parhami; Z T Fang; A M Fogelman; A Andalibi; M C Territo; J A Berliner
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

Authors:  K Uyemura; L L Demer; S C Castle; D Jullien; J A Berliner; M K Gately; R R Warrier; N Pham; A M Fogelman; R L Modlin
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

10.  7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein.

Authors:  G M Chisolm; G Ma; K C Irwin; L L Martin; K G Gunderson; L F Linberg; D W Morel; P E DiCorleto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.